Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-17

FDA Approved: ONDANSETRON — Supplemental Application (JVET PHARMACEUTICALS LLC)

View source ↗

Summary

FDA approved a supplemental application for ondansetron from JVET Pharmaceuticals LLC under an ANDA (generic). The approval covers the use of ondansetron as ind…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)